Allan Arman Kaspar

Title: Allan Arman Kaspar: Innovator in Viral Vector Technology

Introduction

Allan Arman Kaspar is a notable inventor based in Carlsbad, CA (US). He has made significant contributions to the field of viral vector technology, holding 2 patents that showcase his innovative approach to drug product potency and viral vector production.

Latest Patents

His latest patents include a "Cell-based assay for measuring drug product potency." This invention relates to an in vitro quantitative cell-based assay that utilizes a primary mouse cell model system permissive to viral vector infection. It employs a quantitative high-content image-based system for determining the potency of a transgene-expressing viral vector drug product for lot disposition. Another significant patent is titled "Means and method for producing and purifying viral vectors." This patent provides methods for preparing and purifying viral particles, along with compositions and uses comprising the same.

Career Highlights

Allan works at Novartis AG, a leading global healthcare company. His role involves advancing the development of innovative therapies through his expertise in viral vectors. His work has been instrumental in enhancing the efficacy and safety of viral vector-based treatments.

Collaborations

Allan collaborates with esteemed colleagues, including Brian K. Kaspar and Kevin Foust. Their combined expertise fosters a productive environment for innovation and research in the field of biotechnology.

Conclusion

Allan Arman Kaspar's contributions to viral vector technology are noteworthy, as evidenced by his patents and collaborations. His work continues to impact the development of advanced therapeutic solutions in the healthcare industry.